Skip to main content
2106-LB: The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 Diabetes.
2105-LB: Limited Readiness for Type 1 Diabetes (T1D) Autoantibody Screening and Metabolic Monitoring among Pediatric and Adult Diabetes Centers in the T1DX-Quality Improvement Collaborative (T1DX-QI).
1185-P: Determining Accuracy of Continuous Glucose Monitoring in Pediatric Patients in the Inpatient Setting.
1183-P: Neighborhood Level Deprivation Is a Key Predictor of Glycemic Outcomes in Youth-Onset Type 2 Diabetes.
1304-P: MODY Calculator Overestimates MODY Probability in Multiethnic Cohort with Youth-Onset Type 2 Diabetes Phenotype.
146-OR: Clustering Pediatric Type 2 Diabetes Patients Exposes Differential Responses to Therapeutic Interventions.
Increased genetic risk for β-cell failure is associated with β-cell function decline in people with prediabetes.
ß-cell glucose sensitivity to assess changes in ß-cell function in recent onset stage 3 type 1 diabetes.
53-LB: Do the Right Thing—Intensive Intervention and Resulting Costs for Youth with High Social Risk and Type 1 Diabetes (T1D).
727-P: Improvement in Psychosocial Functioning of Youth with Diabetes and Their Caregivers with Multiple Social Risk Factors.